Increase in Incidence of Hepatocellular Carcinoma in Chronic Hepatitis C Chinese After Sustained Virologic Response with Direct Acting Antiviral Agents as Compared to Pegylated Interferon Plus Ribavirin Therapy: A Prospective Open-Label Study
Dong Ji(Humanity & Health), George Lau(Humanity & Health), Gregory Cheng(Humanity & Health), Qing Shao(Newman University), Raymond F. Schinazi(Children's Healthcare of Atlanta), Cheng Wang(Gansu Provincial Maternal and Child Health Hospital), Yu Wang(Northeastern University), Selwyn J. Hurwitz(Emory University), Xiao-Xia Niu(Chinese PLA General Hospital), Ping Han(State Council of the People's Republic of China), Vanessa Wu(Humanity & Health)
Cited by 2
Related Papers
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
|New England Journal of Medicine|2005|1.5k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Zika Virus Infects Human Placental Macrophages
|Cell Host & Microbe|2016|494
The neglected health of international migrant workers in the COVID-19 epidemic
|The Lancet Psychiatry|2020|402